Literature DB >> 15842029

Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial.

E S Paykel1, J Scott, P L Cornwall, R Abbott, C Crane, M Pope, A L Johnson.   

Abstract

BACKGROUND: Although there is good evidence that cognitive therapy (CBT) lessens relapse and recurrence in unipolar depression, the duration of this effect is not known.
METHOD: One hundred and fifty-eight subjects, from a randomized controlled trial of CBT plus medication and clinical management versus medication and clinical management alone, were followed 6 years after randomization (4 1/2 years after completion of CBT) and the longitudinal course assessed.
RESULTS: Effects in prevention of relapse and recurrence were found to persist, with weakening, and were not fully lost until 3 1/2 years after the end of CBT. Residual symptoms were also lessened.
CONCLUSIONS: The effect of CBT in reduction of relapse and recurrence persists for several years. The potential value of subsequent additional CBT some time after cessation should be explored.

Entities:  

Mesh:

Year:  2005        PMID: 15842029     DOI: 10.1017/s003329170400282x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  19 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Cognitive Therapy to Prevent Depressive Relapse in Adults.

Authors:  Jeffrey R Vittengl; Robin B Jarrett
Journal:  Curr Opin Psychol       Date:  2015-08-01

Review 3.  Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.

Authors:  Ranak B Trivedi; Jason A Nieuwsma; John W Williams
Journal:  J Gen Intern Med       Date:  2010-12-24       Impact factor: 5.128

4.  Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.

Authors:  Julie Loebach Wetherell; Jill A Stoddard; Kamila S White; Sander Kornblith; Hoang Nguyen; Carmen Andreescu; Sidney Zisook; Eric J Lenze
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-27       Impact factor: 3.485

Review 5.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 6.  Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators.

Authors:  Ellen Driessen; Steven D Hollon
Journal:  Psychiatr Clin North Am       Date:  2010-09

7.  Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study.

Authors:  Carlos M Grilo; Robert L Stout; John C Markowitz; Charles A Sanislow; Emily B Ansell; Andrew E Skodol; Donna S Bender; Anthony Pinto; M Tracie Shea; Shirley Yen; John G Gunderson; Leslie C Morey; Christopher J Hopwood; Thomas H McGlashan
Journal:  J Clin Psychiatry       Date:  2010-06-15       Impact factor: 4.384

Review 8.  A review of empirically supported psychological therapies for mood disorders in adults.

Authors:  Steven D Hollon; Kathryn Ponniah
Journal:  Depress Anxiety       Date:  2010-10       Impact factor: 6.505

9.  Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Todd W Dunn; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2007-06

Review 10.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.